# TrueBlue, Inc.: financial statements, quarterly

TBI · NYSE · CIK 768899 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/tbi.md) · [Financials](/companies/tbi/financials.md) · [Filings](/companies/tbi/filings.md) · [Insiders](/companies/tbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [473](/filings/0000768899-24-000120.md) | [492 d](/filings/0000768899-26-000009.md) | [403](/filings/0000768899-25-000091.md) | [396](/filings/0000768899-25-000101.md) | [382](/filings/0000768899-25-000113.md) | [386 d](/filings/0000768899-26-000009.md) | [370](/filings/0000768899-26-000019.md) | [396](/filings/0000768899-26-000026.md) | [431](/filings/0000768899-25-000113.md) | [418 d](/filings/0000768899-26-000009.md) | [399](/filings/0000768899-26-000019.md) | [443](/filings/0000768899-26-000026.md) |
| Cost of revenue | $m | [349](/filings/0000768899-24-000120.md) | [364 d](/filings/0000768899-26-000009.md) | [303](/filings/0000768899-25-000091.md) | [292](/filings/0000768899-25-000101.md) | [282](/filings/0000768899-25-000113.md) | [283 d](/filings/0000768899-26-000009.md) | [284](/filings/0000768899-26-000019.md) | [303](/filings/0000768899-26-000026.md) | [333](/filings/0000768899-25-000113.md) | [328 d](/filings/0000768899-26-000009.md) | [320](/filings/0000768899-26-000019.md) | [351](/filings/0000768899-26-000026.md) |
| Gross profit | $m | [124](/filings/0000768899-24-000120.md) | [128 d](/filings/0000768899-26-000009.md) | [99.4](/filings/0000768899-25-000091.md) | [104](/filings/0000768899-25-000101.md) | [100](/filings/0000768899-25-000113.md) | [103 d](/filings/0000768899-26-000009.md) | [86.3](/filings/0000768899-26-000019.md) | [93.6](/filings/0000768899-26-000026.md) | [97.9](/filings/0000768899-25-000113.md) | [90.0 d](/filings/0000768899-26-000009.md) | [79.0](/filings/0000768899-26-000019.md) | [91.6](/filings/0000768899-26-000026.md) |
| Selling, general and administrative | $m | [121](/filings/0000768899-24-000120.md) | [130 d](/filings/0000768899-26-000009.md) | [107](/filings/0000768899-25-000091.md) | [97.0](/filings/0000768899-25-000101.md) | [100.0](/filings/0000768899-25-000113.md) | [107 d](/filings/0000768899-26-000009.md) | [94.6](/filings/0000768899-26-000019.md) | [89.8](/filings/0000768899-26-000026.md) | [91.7](/filings/0000768899-25-000113.md) | [94.9 d](/filings/0000768899-26-000009.md) | [87.3](/filings/0000768899-26-000019.md) | [83.8](/filings/0000768899-26-000026.md) |
| Operating income | $m | [(2.7)](/filings/0000768899-24-000120.md) | [(8.6) d](/filings/0000768899-26-000009.md) | [(15.5)](/filings/0000768899-25-000091.md) | [(60.0)](/filings/0000768899-25-000101.md) | [(6.9)](/filings/0000768899-25-000113.md) | [(10.4) d](/filings/0000768899-26-000009.md) | [(14.1)](/filings/0000768899-26-000019.md) | [(2.9)](/filings/0000768899-26-000026.md) | [(0.1)](/filings/0000768899-25-000113.md) | [(29.4) d](/filings/0000768899-26-000009.md) | [(17.8)](/filings/0000768899-26-000019.md) | [(1.2)](/filings/0000768899-26-000026.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(2.3)](/filings/0000768899-24-000120.md) | [(4.9) d](/filings/0000768899-26-000009.md) | [(12.2)](/filings/0000768899-25-000091.md) | [46.5](/filings/0000768899-25-000101.md) | [1.3](/filings/0000768899-25-000113.md) | [1.7 d](/filings/0000768899-26-000009.md) | [0.4](/filings/0000768899-26-000019.md) | [0.1](/filings/0000768899-26-000026.md) | [0.7](/filings/0000768899-25-000113.md) | [1.1 d](/filings/0000768899-26-000009.md) | [0.6](/filings/0000768899-26-000019.md) | [0.9](/filings/0000768899-26-000026.md) |
| Net income | $m | [(0.0)](/filings/0000768899-24-000120.md) | [(2.6) d](/filings/0000768899-26-000009.md) | [(1.7)](/filings/0000768899-25-000091.md) | [(105)](/filings/0000768899-25-000101.md) | [(7.6)](/filings/0000768899-25-000113.md) | [(11.7) d](/filings/0000768899-26-000009.md) | [(14.3)](/filings/0000768899-26-000019.md) | [(0.2)](/filings/0000768899-26-000026.md) | [(1.9)](/filings/0000768899-25-000113.md) | [(31.5) d](/filings/0000768899-26-000009.md) | [(19.8)](/filings/0000768899-26-000019.md) | [(3.4)](/filings/0000768899-26-000026.md) |
| Diluted EPS | $ per share | [0.00](/filings/0000768899-24-000120.md) | not reported | [(0.05)](/filings/0000768899-25-000091.md) | [(3.45)](/filings/0000768899-25-000101.md) | [(0.26)](/filings/0000768899-25-000113.md) | not reported | [(0.48)](/filings/0000768899-26-000019.md) | [(0.01)](/filings/0000768899-26-000026.md) | [(0.06)](/filings/0000768899-25-000113.md) | not reported | [(0.66)](/filings/0000768899-26-000019.md) | [(0.11)](/filings/0000768899-26-000026.md) |
| Basic EPS | $ per share | [0.00](/filings/0000768899-24-000120.md) | not reported | [(0.05)](/filings/0000768899-25-000091.md) | [(3.45)](/filings/0000768899-25-000101.md) | [(0.26)](/filings/0000768899-25-000113.md) | not reported | [(0.48)](/filings/0000768899-26-000019.md) | [(0.01)](/filings/0000768899-26-000026.md) | [(0.06)](/filings/0000768899-25-000113.md) | not reported | [(0.66)](/filings/0000768899-26-000019.md) | [(0.11)](/filings/0000768899-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [47.1](/filings/0000768899-23-000128.md) | [61.9](/filings/0000768899-25-000043.md) | [36.2](/filings/0000768899-24-000085.md) | [26.4](/filings/0000768899-24-000102.md) | [14.5](/filings/0000768899-24-000120.md) | [22.5](/filings/0000768899-26-000009.md) | [23.1](/filings/0000768899-25-000091.md) | [21.9](/filings/0000768899-25-000101.md) | [19.9](/filings/0000768899-25-000113.md) | [24.5](/filings/0000768899-26-000026.md) | [24.1](/filings/0000768899-26-000019.md) | [23.3](/filings/0000768899-26-000026.md) |
| Current assets | $m | [360](/filings/0000768899-23-000128.md) | [355](/filings/0000768899-25-000043.md) | [315](/filings/0000768899-24-000085.md) | [301](/filings/0000768899-24-000102.md) | [285](/filings/0000768899-24-000120.md) | [277](/filings/0000768899-26-000009.md) | [281](/filings/0000768899-25-000091.md) | [287](/filings/0000768899-25-000101.md) | [313](/filings/0000768899-25-000113.md) | [298](/filings/0000768899-26-000026.md) | [301](/filings/0000768899-26-000019.md) | [318](/filings/0000768899-26-000026.md) |
| Total assets | $m | [915](/filings/0000768899-23-000128.md) | [899](/filings/0000768899-25-000043.md) | [869](/filings/0000768899-24-000085.md) | [724](/filings/0000768899-24-000102.md) | [702](/filings/0000768899-24-000120.md) | [675](/filings/0000768899-26-000009.md) | [692](/filings/0000768899-25-000091.md) | [673](/filings/0000768899-25-000101.md) | [691](/filings/0000768899-25-000113.md) | [639](/filings/0000768899-26-000026.md) | [621](/filings/0000768899-26-000019.md) | [623](/filings/0000768899-26-000026.md) |
| Current liabilities | $m | [201](/filings/0000768899-23-000128.md) | [204](/filings/0000768899-25-000043.md) | [184](/filings/0000768899-24-000085.md) | [158](/filings/0000768899-24-000102.md) | [155](/filings/0000768899-24-000120.md) | [160](/filings/0000768899-26-000009.md) | [156](/filings/0000768899-25-000091.md) | [148](/filings/0000768899-25-000101.md) | [156](/filings/0000768899-25-000113.md) | [139](/filings/0000768899-26-000026.md) | [144](/filings/0000768899-26-000019.md) | [139](/filings/0000768899-26-000026.md) |
| Total liabilities | $m | [458](/filings/0000768899-23-000128.md) | [442](/filings/0000768899-25-000043.md) | [422](/filings/0000768899-24-000085.md) | [386](/filings/0000768899-24-000102.md) | [375](/filings/0000768899-24-000120.md) | [360](/filings/0000768899-26-000009.md) | [390](/filings/0000768899-25-000091.md) | [368](/filings/0000768899-25-000101.md) | [386](/filings/0000768899-25-000113.md) | [364](/filings/0000768899-26-000026.md) | [365](/filings/0000768899-26-000019.md) | [368](/filings/0000768899-26-000026.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0000768899-25-000043.md) | not reported | not reported | not reported | [7.6](/filings/0000768899-26-000009.md) | [57.8](/filings/0000768899-25-000091.md) | [53.8](/filings/0000768899-25-000101.md) | [68.2](/filings/0000768899-25-000113.md) | [65.8](/filings/0000768899-26-000026.md) | [73.9](/filings/0000768899-26-000019.md) | [82.4](/filings/0000768899-26-000026.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [457](/filings/0000768899-24-000120.md) | [458](/filings/0000768899-26-000009.md) | [446](/filings/0000768899-25-000091.md) | [338](/filings/0000768899-25-000101.md) | [327](/filings/0000768899-25-000113.md) | [315](/filings/0000768899-26-000009.md) | [302](/filings/0000768899-26-000019.md) | [305](/filings/0000768899-26-000026.md) | [304](/filings/0000768899-25-000113.md) | [275](/filings/0000768899-26-000026.md) | [256](/filings/0000768899-26-000019.md) | [255](/filings/0000768899-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.3) d](/filings/0000768899-24-000120.md) | [15.2 d](/filings/0000768899-26-000009.md) | [(14.2)](/filings/0000768899-25-000091.md) | [(1.8) d](/filings/0000768899-25-000101.md) | [(7.1) d](/filings/0000768899-25-000113.md) | [6.1 d](/filings/0000768899-26-000009.md) | [(22.1)](/filings/0000768899-26-000019.md) | [(11.8) d](/filings/0000768899-26-000026.md) | [(19.8) d](/filings/0000768899-25-000113.md) | [(4.4) d](/filings/0000768899-26-000009.md) | [(9.8)](/filings/0000768899-26-000019.md) | [(20.6) d](/filings/0000768899-26-000026.md) |
| Capital expenditure | $m | [7.4 d](/filings/0000768899-24-000120.md) | [8.2 d](/filings/0000768899-26-000009.md) | [7.4](/filings/0000768899-25-000091.md) | [5.9 d](/filings/0000768899-25-000101.md) | [5.6 d](/filings/0000768899-25-000113.md) | [5.3 d](/filings/0000768899-26-000009.md) | [4.7](/filings/0000768899-26-000019.md) | [4.3 d](/filings/0000768899-26-000026.md) | [3.6 d](/filings/0000768899-25-000113.md) | [3.1 d](/filings/0000768899-26-000009.md) | [2.8](/filings/0000768899-26-000019.md) | [3.4 d](/filings/0000768899-26-000026.md) |
| Share repurchases | $m | [(0.0) d](/filings/0000768899-24-000120.md) | [0.0 d](/filings/0000768899-26-000009.md) | [10.1](/filings/0000768899-25-000091.md) | [6.9 d](/filings/0000768899-25-000101.md) | [4.3 d](/filings/0000768899-25-000113.md) | [(0.0) d](/filings/0000768899-26-000009.md) | [0.0](/filings/0000768899-25-000091.md) | [0.0 d](/filings/0000768899-25-000101.md) | [0.0 d](/filings/0000768899-25-000113.md) | [0.0 d](/filings/0000768899-26-000009.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.8](/filings/0000768899-23-000128.md) | [32.3](/filings/0000768899-24-000085.md) | [31.0](/filings/0000768899-24-000102.md) | [30.9](/filings/0000768899-24-000120.md) | [31.1](/filings/0000768899-25-000091.md) | [30.3](/filings/0000768899-25-000101.md) | [29.7](/filings/0000768899-25-000113.md) | [29.7](/filings/0000768899-26-000019.md) | [29.9](/filings/0000768899-26-000026.md) | [29.9](/filings/0000768899-25-000113.md) | [30.1](/filings/0000768899-26-000019.md) | [30.4](/filings/0000768899-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,444,344 at 2026-07-26, from the cover of the [10-Q filed 2026-08-04](/filings/0000768899-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.